Scott-Woo G C, Walsh M P
Department of Medical Biochemistry, Faculty of Medicine, University of Calgary, Alberta, Canada.
Biochem J. 1988 Nov 1;255(3):817-24. doi: 10.1042/bj2550817.
Caldesmon, an actin- and calmodulin-binding protein of smooth muscle, is a protein serine/threonine kinase capable of Ca2+/calmodulin-dependent autophosphorylation [Scott-Woo & Walsh (1988) Biochem. J. 252, 463-472]. Phosphorylation nullifies the inhibitory effect of caldesmon on the actin-activated Mg2+-ATPase activity of smooth-muscle myosin [Ngai & Walsh (1987) Biochem. J. 244, 417-425]. We have characterized the kinase activity of caldesmon of chicken gizzard smooth muscle. Autophosphorylation requires Ca2+/calmodulin, but is unaffected by other second messengers (Ca2+/phospholipid/diacylglycerol, cyclic AMP or cyclic GMP), and is inhibited by the calmodulin antagonists chlorpromazine and compound 48/80, with 50% inhibition at 39.8 microM and 12.0 ng/ml respectively. Half-maximal activation of autophosphorylation occurs at 60-80 nM-Ca2+ and 0.14 microM-calmodulin, and maximal activity at 0.14-0.18 microM-Ca2+ and 1 microM-calmodulin; activation is gradually lost at higher Ca2+ and calmodulin concentrations. Autophosphorylation is pH-dependent, with maximal activity over the range pH 7-9, and requires free Mg2+ in addition to the MgATP2- substrate. The Km for ATP is 15.6 +/- 4.1 microM (mean +/- S.D., n = 4), and kinase activity is inhibited by increasing ionic strength [half-maximal inhibition at I = 0.094 +/- 0.009 M (mean +/- S.D., n = 4)]. Autophosphorylation does not affect the rate of hydrolysis of caldesmon (free or bound to calmodulin) by alpha-chymotrypsin. However, a slight difference in peptides generated from phospho- and dephospho-forms of caldesmon is observed. The binding of phospho- or dephospho-caldesmon to F-actin protects the protein against chymotryptic digestion, but does not alter the pattern of peptide generation. Characterization of proteolytic fragments of caldesmon generated by alpha-chymotrypsin and Staphylococcus aureus V8 protease enables localization of the phosphorylation sites and the kinase active site within the caldesmon molecule.
钙调蛋白是一种平滑肌中与肌动蛋白和钙调蛋白结合的蛋白质,是一种能够进行Ca2+/钙调蛋白依赖性自身磷酸化的蛋白质丝氨酸/苏氨酸激酶[斯科特 - 吴和沃尔什(1988年)《生物化学杂志》252卷,463 - 472页]。磷酸化消除了钙调蛋白对平滑肌肌球蛋白肌动蛋白激活的Mg2+-ATP酶活性的抑制作用[恩盖和沃尔什(1987年)《生物化学杂志》244卷,417 - 425页]。我们已经对鸡肫平滑肌钙调蛋白的激酶活性进行了表征。自身磷酸化需要Ca2+/钙调蛋白,但不受其他第二信使(Ca2+/磷脂/二酰基甘油、环磷酸腺苷或环磷酸鸟苷)的影响,并且受到钙调蛋白拮抗剂氯丙嗪和化合物48/80的抑制,分别在39.8 microM和12.0 ng/ml时抑制50%。自身磷酸化的半最大激活发生在60 - 80 nM - Ca2+和0.14 microM - 钙调蛋白时,最大活性在0.14 - 0.18 microM - Ca2+和1 microM - 钙调蛋白时;在更高的Ca2+和钙调蛋白浓度下激活逐渐丧失。自身磷酸化依赖于pH值,在pH 7 - 9范围内活性最大,并且除了MgATP2-底物外还需要游离Mg2+。ATP的Km为15.6 +/- 4.1 microM(平均值 +/- 标准差,n = 4),并且激酶活性受到离子强度增加的抑制[在I = 0.094 +/- 0.009 M(平均值 +/- 标准差,n = 4)时半最大抑制]。自身磷酸化不影响α-胰凝乳蛋白酶对钙调蛋白(游离或与钙调蛋白结合)的水解速率。然而,可以观察到从钙调蛋白的磷酸化和去磷酸化形式产生的肽段存在轻微差异。磷酸化或去磷酸化的钙调蛋白与F-肌动蛋白的结合保护该蛋白质免受胰凝乳蛋白酶消化,但不改变肽段产生的模式。对由α-胰凝乳蛋白酶和金黄色葡萄球菌V8蛋白酶产生的钙调蛋白蛋白水解片段的表征能够确定钙调蛋白分子内的磷酸化位点和激酶活性位点。